MedX Health redeems secured convertible debentures worth USD 2.965M

MedX Health Corp. is pleased to announce that, effective November 17, 2023, $2,965,000 of Secured Convertible Debentures were fully redeemed pursuant to exercise of the Conversion Rights by the Holders, resulting issuance of 59,300,000 common shares and 59,300,000 share purchase warrants exercisable at $0.20 until December 31, 2027.

“This conversion of this Secured Debt sends a strong message of confidence in the future of MedX and continued support by the former debt-holders, and has eliminated of all the secured debt from the Company’s Balance Sheet. This positive step will greatly help the Company move forward with the ongoing roll-out of its SIAscopy® on DermSecure® telemedicine platform,” said Stephen Lockyer, CEO of MedX.
MB Bureau